By Darrin LaVelle, Founder of RENVA Health
Last updated: July 4, 2026
If you're evaluating a telehealth GLP-1 program, or comparing more than one, this is the complete list of questions worth getting clear answers to before you commit — organized into medication, clinical oversight, cost, and program quality. A provider who answers these clearly and specifically is telling you something important; so is one who can't.
You don't need a medical background to ask good questions before starting GLP-1 treatment — you just need to know what to ask. This pulls together the questions that actually matter, based on clinical guidance and documented patterns in how GLP-1 programs vary in quality.
Semaglutide, tirzepatide, liraglutide, and orforglipron aren't interchangeable — they differ in effectiveness, side-effect profile, and route of administration. A good answer should connect the specific choice to your health conditions, prior treatments, and preferences, not just default to whatever the provider stocks.
FDA-approved brand-name products have been reviewed for safety, effectiveness, and manufacturing quality. Compounded versions haven't, and some have used different active ingredient forms than advertised. If compounded medication is being offered, ask specifically why — a documented shortage or individual medical need is a legitimate reason; lower cost alone is a different conversation. (See our full guide on compounded vs. brand-name GLP-1.)
Standard schedules start low and increase roughly every 4 weeks specifically to minimize side effects. Ask to see the actual schedule you'll be following, and whether it matches the FDA-approved label for your specific medication. (See our dose titration schedule guide for what standard schedules actually look like.)
A good program should have a clear plan — slowing titration, temporarily reducing dose, or adjusting meal timing and composition — rather than a vague "call us if something's wrong."
GLP-1 medications have experienced real shortages before. Ask how the program plans to handle interruptions, including whether restarting would mean going back through titration from a lower dose.
Common baseline labs include blood sugar markers, a metabolic panel covering kidney function, a lipid panel, and often liver function and thyroid tests. If a program requires zero labs, that's worth understanding why. (See our baseline labs guide for what's typically recommended and why.)
Beyond weight itself, this should include BMI, waist circumference, blood pressure, and relevant lab markers over time — not just a scale check-in.
Programs vary significantly here — some offer monthly contact during titration and quarterly after; others provide a single initial call and minimal follow-up. Limited follow-up has been specifically associated with more gaps in nutrition guidance and side-effect management in telehealth research.
You should know in advance whether that means calling the clinic, using an after-hours line, or going straight to emergency care — not figuring it out in the moment.
You're entitled to know whether you're working with a physician, nurse practitioner, or physician assistant, and to have a named, accountable clinician — not an anonymous rotating pool.
Ask specifically about membership fees, the medication cost itself, lab costs, and shipping — some programs advertise a low subscription price that doesn't include the medication, which can still run several hundred dollars a month on top.
Ask whether the program helps with appeals, offers a covered alternative medication, or can point you toward manufacturer savings programs. (See our insurance coverage guide and, if you're on Medicare, our Medicare GLP-1 Bridge guide for what's currently available.)
Ask specifically whether it's dispensed through the original manufacturer's pharmacy network, a state-licensed compounding pharmacy, or a registered outsourcing facility — and confirm you can independently verify whatever they tell you. (See our guide on how to verify a compounding pharmacy for exactly how to check.)
Some subscription-based programs auto-renew and charge fees even when a prescription gets delayed or denied. Ask directly about notice requirements and refund policy for months where no medication is actually provided.
A transparent program keeps evaluation fees clearly separate from medication costs, and shouldn't charge you for medication you never receive.
A quality program should be able to point to recognized standards — professional obesity medicine guidelines, endocrine society guidance, or similar — that shape their eligibility criteria and monitoring approach, rather than an internally invented protocol.
This matters more than it might seem. Research has found that a meaningful share of weight lost on these medications is lean muscle rather than fat, and that most clinical trials didn't include structured dietitian support at all. Ask specifically whether a registered dietitian is involved, not just whether "nutrition guidance" is mentioned somewhere in the marketing. (See our muscle loss and nutrition guide for why this matters.)
Since stopping these medications is strongly associated with significant weight regain, ask whether the program has an actual long-term strategy — continued treatment, dose adjustments, or a documented plan for any eventual step-down — rather than being structured around a short-term engagement. (See our guide on what happens if you stop taking GLP-1 medications for the data behind why this matters.)
Plateaus are an expected, normal part of treatment, not a sign of failure. A good program should have a clear answer for how they respond when this happens, rather than treating it as a surprise. (See our GLP-1 timeline guide for what a normal trajectory looks like.)
This is the meta-question behind all the others. A program that sets clear, honest, individually-tailored expectations — about timeline, likely results, and what long-term treatment actually involves — is a different experience than one selling a fast, simple, one-size-fits-all promise.
Not every question needs a perfect answer to move forward — some, like exact long-term plans, reasonably depend on how your treatment progresses. What matters more is whether a provider engages with these questions directly and specifically, versus deflecting, minimizing, or not being able to answer at all. Vague or evasive answers to questions about pharmacy sourcing, cancellation terms, or who's actually overseeing your care are worth treating as real signal, not just an awkward conversation to get past.
Q: Is it reasonable to ask a provider all of these questions before committing?
Yes — a legitimate, quality-focused provider should welcome direct questions about their process, sourcing, and policies. Reluctance to answer clearly is itself useful information.
Q: What if a provider can't answer some of these questions immediately?
It's reasonable for some answers to require checking with a pharmacist or specific team member — what matters is whether you get a clear, specific answer eventually, not necessarily instantly.
Q: Should I ask these questions before or after paying anything?
Before, whenever possible. Ideally before any non-refundable fee is charged, since questions about cancellation policy and evaluation-fee refunds are most useful to ask before you're already financially committed.
Q: Do these questions apply to in-person providers too, or just telehealth?
Nearly all of them apply equally to in-person care — the medication, clinical oversight, and program quality questions aren't telehealth-specific. A few of the logistics questions (like pharmacy verification) are especially relevant for telehealth given the added layer of remote dispensing.
Q: Which of these questions matters most if I can only ask a few?
Medication source (brand vs. compounded), true all-in cost, and whether nutrition support is genuinely included tend to reveal the most about program quality with the fewest questions asked.
See also: How to Get Prescribed a GLP-1 Medication for the full evaluation and prescribing process, and Do You Need Labs Before Starting? for what baseline bloodwork is typically recommended and why.
Medical disclaimer: RENVA is not a healthcare provider. This article is informational and educational only. It does not constitute medical advice, diagnosis, or a prescription. Always consult a licensed healthcare professional before making health decisions. Full medical disclaimer →
Answer a few preference questions — budget, labs, provider model, and cancellation flexibility. Preference-based and informational only.
Take the free quizWhat it actually takes to get prescribed Wegovy, Zepbound, or another GLP-1 medication — eligibility criteria, the evaluation process, insurance steps, and realistic timelines.
Compounded GLP-1 medications aren't FDA-approved and aren't reviewed for safety or quality before they're sold. Here's what that actually means and why the distinction matters.
The FDA doesn't require specific labs before starting a GLP-1 medication, but clinical guidelines recommend a standard set. Here's what's typically tested and why.